Acquisition Alignment Target Tentamus network integration post acquisition to leverage EuTech’s contract research capabilities in analytical method development and validation for pharma, medical devices, and nutraceutical clients seeking consolidation of testing partners.

Niche Expertise Position EuTech as a specialist CRO for analytical method development and re-use of existing methods, offering high-quality, knowledge-based services to pharmaceutical and biotech firms looking to optimize assay development and method transfer.

SMB to Midmarket Leverage revenue range and small team profile to engage mid-market pharmaceutical and nutraceutical companies seeking flexible, hands-on CRO partners with personalized service and rapid turnaround.

Global Collaboration Highlight potential for cross-border or networked projects within Tentamus and related groups to scale capabilities, share best practices, and access broader testing portfolios across multiple countries.

Growth Signals Capitalize on established track record since 1994 and ongoing demand for analytical method development, enabling sales pitches around continuity, quality, and risk mitigation for customers with complex regulatory requirements.